Location History:
- Le Cres, FR (2018)
- Les Matelles, FR (2022 - 2024)
Company Filing History:
2 out of 3,539 
2 out of 998 
1 out of 4 Years Active: 2018-2024
Title: Innovations of Berengere Vire: Pioneering Advances in Biomedical Research
Introduction
Berengere Vire, a notable inventor based in Les Matelles, France, has made significant contributions to the field of biomedical research. With a portfolio of three patents, she is advancing our understanding of mood disorders and cancer therapy through innovative methodologies.
Latest Patents
Among her latest patents, Vire has developed a groundbreaking method for RNA editing as biomarkers for mood disorders. This invention focuses on predicting the risk of developing psychiatric disorders through alterations in A-to-I editing on PDE8A transcripts. Utilizing body fluids such as blood, urine, or saliva, this method offers a promising avenue for early diagnosis and intervention. Additionally, her patent on an antibody targeting cell surface deposited complement protein C3d outlines a method to employ anti-C3d antibodies or fragments to effectively kill cancer cells. This invention is accompanied by related methods and compositions, showcasing her commitment to addressing critical health issues.
Career Highlights
Throughout her career, Berengere Vire has collaborated with esteemed institutions such as the U.S. Department of Health and Human Services and the University of Virginia Patent Foundation. Her innovative spirit and dedication to research have paved the way for advancements in therapeutic strategies.
Collaborations
Vire has collaborated with notable professionals including Adrian U Wiestner and Martin W Skarzynski. These partnerships highlight her ability to work alongside leading experts in the field, further enhancing her contributions to biomedical research.
Conclusion
In summary, Berengere Vire's innovations represent a remarkable intersection of scientific inquiry and practical application. Her patents not only reflect her expertise but also her dedication to improving patient care in the realms of mood disorders and cancer treatment. As her career continues to evolve, the impact of her work is sure to resonate within the scientific community and beyond.